Blood

Vol. 146, Issue Supplement 1 Issue Supplement 1 2025
8248
Articles

Articles in this Issue

Unveiling prognostic subtypes in myelofibrosis through routine blood counts: A population-based analysis of the cytopenic and proliferative phenotypes in andalusia, Spain

Regina Garcia Delgado, Alejandro Escamilla Sánchez, Alberto Esteban Medina et al. Nov 03, 2025 pp. 7355-7355 10.1182/blood-2025-7355

Abstract Background Most published myelofibrosis (MF) data come from clinical trials or hospital registries, mainly from large centers, with...

Ravulizumab demonstrates real-world effectiveness in patients with paroxysmal nocturnal hemoglobinuria: A US chart review study

David Dingli, Andrew Messali, Arpita Nag et al. Nov 03, 2025 pp. 8010-8010 10.1182/blood-2025-8010

Abstract Background Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disorder characterized by uncontrolled ter...

Autologous, allogeneic haemopoietic stem cell transplantation and CART cell therapy for tranformed Waldenström's macroglobulinemia to high grade non-Hodgkin lymphoma. real world outcomes report from the lymphoma working party of the european society for blood and marrow transplantation (LWP EBMT)

Charalampia Kyriakou, Maud Ngoya, Nour Moukalled et al. Nov 03, 2025 pp. 3718-3718 10.1182/blood-2025-3718

Abstract Introduction: High grade transformation of Waldenstrom's Macroglobulinemia (tWM) is a rare but serious complication and there is lim...

Eccdna-encoded LIPIN1 drives DGAT1-dependent lipid droplet biogenesis to promote Acute Myeloid Leukemia progression and chemoresistance

Wancheng Liu, Amin Zhang, XiangLing Xing et al. Nov 03, 2025 pp. 3489-3489 10.1182/blood-2025-3489

Abstract Introduction: Extrachromosomal circular DNA (eccDNA) has emerged as a critical player in cancer biology. Accumulating evidence indic...

A mouse model of aggressive ATL associated with oncogenic mutations and an HBZ-expressing hematopoietic environment

Takuro Kameda, Kotaro Shide, Yuki Tahira et al. Nov 03, 2025 pp. 1482-1482 10.1182/blood-2025-1482

Abstract [Introduction] Adult T-cell leukemia/lymphoma (ATL) is a peripheral T-cell malignancy that develops decades after HTLV-1 infection....

Liver knock-out of nuclear inhibitor of protein phosphatase-1 in mice decreases hepatic iron

Asrar Ahmad, Tatiana Ammosova, Papa Hoyeck et al. Nov 03, 2025 pp. 4680-4680 10.1182/blood-2025-4680

Abstract The liver plays a critical role in iron homeostasis and serves as the iron recycling and storage place. It also produces hepcidin,...

Acute myocardial infarction following allogeneic hematopoietic stem cell transplantation: Lessons learned from a national representative study

Peng Zhao, Zhixue Li, Erlie Jiang et al. Nov 03, 2025 pp. 4263-4263 10.1182/blood-2025-4263

Abstract Introduction Acute myocardial infarction (MI) is a rare but life-threatening complication following allogeneic hematopoietic stem c...

Subcutaneous, every-four-week maintenance dosing of a novel protein S antibody is well-tolerated and substantially reduces bleeding rates: Results from A phase 1/2 multidose study of VGA039 in patients with von Willebrand disease

Allison Wheeler, Shrinath Kshirsagar, Adam Giermasz et al. Nov 03, 2025 pp. 308-308 10.1182/blood-2025-308

Abstract Introduction: Patients with von Willebrand Disease (VWD) experience frequent, prolonged bleeding of variable types and severity. Re...

Computational profiling of predicted neoantigen landscape reveals differential immunogenicity at AML diagnosis and relapse

Othmane Jadi, Steven Vensko, Benjamin Vincent Nov 03, 2025 pp. 3480-3480 10.1182/blood-2025-3480

Abstract Introduction Although AML carries a relatively low mutational burden and was once considered poorly immunogenic, immune escape has n...

Lymphoma are the most frequent secondary hematologic malignancies following solid tumors: A large cohort study from the german cancer registry nrw

Amin Turki, Ina Wellmann, Hiltraud Kajüter et al. Nov 03, 2025 pp. 4519-4519 10.1182/blood-2025-4519

Abstract Background: Cancer survivorship faces many challenges, including secondary malignancies. Several studies have examined neoplasms af...

Second Primary Malignancy in Multiple Myeloma: a retrospective monocentric analysis of Department of Hematology of the Oncologic Hospital from Cagliari

Daniele Derudas, Cristian Loi, Rita Floris et al. Nov 03, 2025 pp. 7559-7559 10.1182/blood-2025-7559

Abstract Background: Novel agents have changed the treatment landscape of multiple myeloma (MM). The improvement in treatment outcomes of MM...

Disruption of the gut microbiota promotes chronic inflammation in JAK2V617F-driven MPN: Evidence from mouse and human studies

Althea Agdamag, Zixing Huang, Anisa Azatovna Gumerova et al. Nov 03, 2025 pp. 360-360 10.1182/blood-2025-360

Abstract Elevated levels of pro-inflammatory cytokines are linked to increased thrombotic risk and disease progression in myeloproliferative...

Early detection of emerging safety signals in GVHD prophylaxis agents using a 12-year faers “slope-watch” approach

Manzer Ali, Bolivia Fernandes, Rajesh Thirumaran et al. Nov 03, 2025 pp. 7767-7767 10.1182/blood-2025-7767

Abstract Background: Over the past decade, the prevention of graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell trans...

Outcomes with dasatinib in Philadelphia Chromosome–Positive acute lymphoblastic leukemia: A systematic review and meta-analysis

Muhammad Kashif Amin, Hafiz Muhammad Hannan Javed, Zeeshan Sattar et al. Nov 03, 2025 pp. 6869-6869 10.1182/blood-2025-6869

Abstract Introduction: Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) is a high-risk leukemia subtype with limited...

Advanced practice provider led programs improve patient access: The APP lymphoma diagnostic program

Kurt Bantilan, Jenna Wenzel, Lauren Drosick et al. Nov 03, 2025 pp. 284-284 10.1182/blood-2025-284

Abstract Purpose: Lymphoma consists of a heterogeneous group of cancers that range from indolent to aggressive, and differentiating malignan...

Racial disparities in survival trends in burkitt lymphoma in the CAR-T cell therapy era vs pre-CAR-T cell therapy era in the United States: A population-based study

Dosbai Saparov, Henry Becerra, Azamat Abdyraimov et al. Nov 03, 2025 pp. 7185-7185 10.1182/blood-2025-7185

Abstract Background: Burkitt lymphoma (BL) is an uncommon and aggressive B cell non-Hodgkin lymphoma (NHL) that develops...

Closing analysis of the patient and disease characteristics of the UK primary paediatric ITP registry

Mia Giles, Haroon Miah, Nichola Cooper et al. Nov 03, 2025 pp. 4808-4808 10.1182/blood-2025-4808

Abstract Introduction: Immune thrombocytopenia (ITP) is a rare autoimmune disorder characterised antibody-mediated platelet and megakaryocyt...

Long-term follow-up of the first in human post-transcriptional genetic silencing of BCL11A in sickle cell disease in a phase 1 pilot and feasibility trial

Erica Esrick, Leslie Lehmann, Amy Federico et al. Nov 03, 2025 pp. 2533-2533 10.1182/blood-2025-2533

Abstract We conducted a first-in-human phase 1 dose-finding pilot and feasibility study testing the safety of gene therapy using a lentiviru...

Prognostic impact of cytogenetic abnormalities in aggressive T-cell lymphomas: Defining high-risk subgroups through conventional karyotyping.

Ahmad Kiwan, Autumn Diadamo, Jia Di Wen et al. Nov 03, 2025 pp. 1759-1759 10.1182/blood-2025-1759

Abstract Introduction Mature T-cell lymphomas, including aggressive nodal PTCL, advanced stage CTCL, and extranodal cytotoxic lymphomas, are...

Tet2 clonal hematopoiesis enhances thrombotic pathologies, increases platelet reactivity, and alters megakaryote function in the context of aging

Virginia Camacho, Estelle Carminita, Maria Barrachina et al. Nov 03, 2025 pp. 4946-4946 10.1182/blood-2025-4946

Abstract Cardiovascular diseases (CVDs)—including heart attacks, strokes, and thrombotic events—account for over 80% of deaths in individual...

Description of neurocognition in adult sickle cell disease patients using the NIH toolbox

Olivia Perez De Acha, Iris Rahman, Terrell Coring et al. Nov 03, 2025 pp. 4716-4716 10.1182/blood-2025-4716

Abstract Background: Increasingly studied are the neurocognitive complications in adults with SCD. The most common presentation of such is a...

A clinical case study: the potential impact of maternal anti-Co4 antibody on Pregnancy Conceived by in vitro fertilization (IVF)

Abdus Salam, Camila Sahebi, Shabrina Shah et al. Nov 03, 2025 pp. 6691-6691 10.1182/blood-2025-6691

Abstract The Colton blood group system (CO, ISBT 015), is a blood group system characterized by antigens present on aquaporin-1 (AQP1), a mu...

Genomic insights and risk stratification in AML: Findings from a uniquely young national cohort in Qatar (AML-QC)

Amna Gameil, Mahmoud Hailk, Feryal Hilmi et al. Nov 03, 2025 pp. 6928-6928 10.1182/blood-2025-6928

Abstract Background Acute myeloid leukemia (AML) is a heterogeneous stem cell malignancy marked by considerable genetic and clinical variabi...

Cytoskeletal rearrangements and SRC signalling defects controlled by PP1β drive impaired megakaryocyte maturation and platelet production

Gabriel Araujo, Maximilian Englert, Audrey Chang et al. Nov 03, 2025 pp. 4961-4961 10.1182/blood-2025-4961

Abstract Platelet production is a highly regulated process involving coordinated signaling and cytoskeletal remodeling. While thrombopoietin...

CAR T cell-driven induction of iNOS in tumor associated macrophages promotes CAR T cell resistance in B cell lymphoma

Sae Bom Lee, Yun Pyo Kang, Justin Boucher et al. Nov 03, 2025 pp. 558-558 10.1182/blood-2025-558

Abstract Chimeric antigen receptor (CAR) T cell therapies have revolutionized B cell malignancy treatment, but subsets of patients with larg...

All Issues

Journal Info

Publisher Elsevier BV
ISSN 0006-4971
E-ISSN 1528-0020
Subject Health Sciences
Language English
View Full Journal Page